Overall and Sex-Based Risk Factors for Hyperprolactinemia in Patients With Schizophrenia: A Retrospective Cohort Study
Multiple pharmacological and non-pharmacological factors contribute to HPRL in patients with schizophrenia, with notable sex-specific differences. The potential role of HPRL in breast cancer development among female patients requires further investigation.
Authors
- Zhenjing Liu (ORCID: https://orcid.org/0000-0003-4020-1774)
- Li Li (ORCID: https://orcid.org/0000-0002-7128-4085)
- Yan Yang (ORCID: https://orcid.org/0000-0002-9479-6817)
- Xiaoqin Chen
- Hui He
- Mi Yang (ORCID: https://orcid.org/0000-0003-0690-322X)
Institutions
- University of Electronic Science and Technology of China (CN)
- The Fourth People's Hospital (CN)
- Qingdao Mental Health Center (CN)
- Fourth People's Hospital of Sichuan Province (CN)
Publication Details
- Journal
- Current Neuropharmacology
- Published
- 2026-01-13
- DOI
- https://doi.org/10.2174/011570159x396058251125043723
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00